Thomas Holm Pedersen speaks at The Global CMT Research Convention

Will you be attending the Global CMT Research Convention this Friday and Saturday, 16-17 September in Cambridge, MA?
The event is the largest global convention focussed on Charcot-Marie-Tooth, bringing together the research community and patients in a single event.

Join our CEO, Thomas Holm Pedersen on Saturday 17 Sep where he’ll be speaking as a panellist on the ‘Surge of Momentum from Biotechs’ panel at 2:30-3:45pm EDT discussing NMD Pharma’s work on CMT.

Previous
Previous

FDA grants Orphan Drug Designation for NMD670 for the Treatment of Myasthenia Gravis

Next
Next

The INCUBA Awards